Oppenheimer has maintained its outperform rating on Microsoft.Goldman Sachs has added chemical company Celanese to its conviction buy list.UBS has upgraded AT and T to a buy,with a price target of 31.00.It has also added Pfizer to its conviction buy list on valuation.
No comments:
Post a Comment